{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:32:25Z","timestamp":1780407145546,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fondation Bordeaux Universit\u00e9","award":["Fondation Bordeaux Universit\u00e9"],"award-info":[{"award-number":["Fondation Bordeaux Universit\u00e9"]}]},{"name":"Mutuelles AXA","award":["Mutuelles AXA"],"award-info":[{"award-number":["Mutuelles AXA"]}]},{"name":"Th\u00e9a Pharma","award":["Th\u00e9a Pharma"],"award-info":[{"award-number":["Th\u00e9a Pharma"]}]},{"name":"Macu-Life Project","award":["Macu-Life Project"],"award-info":[{"award-number":["Macu-Life Project"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00417-025-07062-7","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T03:03:37Z","timestamp":1766027017000},"page":"731-741","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of current Statin use with incident age-related macular degeneration: using time-varying propensity scores"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6985-2450","authenticated-orcid":false,"given":"Blondy","family":"Kayembe-Mulumba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Leffondr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2486-632X","authenticated-orcid":false,"given":"Petra P.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9milie","family":"Hucteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Korobelnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2099-0481","authenticated-orcid":false,"given":"C\u00e9cile","family":"Delcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3127-8617","authenticated-orcid":false,"given":"Marie-No\u00eblle","family":"Delyfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"7062_CR1","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","volume":"9","author":"JD Steinmetz","year":"2021","unstructured":"Steinmetz JD, Bourne RRA, Briant PS et al (2021) Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health 9:e144\u2013e160. https:\/\/doi.org\/10.1016\/S2214-109X(20)30489-7","journal-title":"Lancet Glob Health"},{"key":"7062_CR2","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","volume":"392","author":"P Mitchell","year":"2018","unstructured":"Mitchell P, Liew G, Gopinath B, Wong TY (2018) Age-related macular degeneration. Lancet 392:1147\u20131159. https:\/\/doi.org\/10.1016\/S0140-6736(18)31550-2","journal-title":"Lancet"},{"key":"7062_CR3","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X et al (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2:e106\u2013e116. https:\/\/doi.org\/10.1016\/S2214-109X(13)70145-1","journal-title":"Lancet Glob Health"},{"key":"7062_CR4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1001\/jama.2022.12138","volume":"328","author":"R Chou","year":"2022","unstructured":"Chou R, Cantor A, Dana T et al (2022) Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US preventive services task force. JAMA 328:754\u2013771. https:\/\/doi.org\/10.1001\/jama.2022.12138","journal-title":"JAMA"},{"key":"7062_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.preteyeres.2018.04.006","volume":"67","author":"EM Van Leeuwen","year":"2018","unstructured":"Van Leeuwen EM, Emri E, Merle BMJ et al (2018) A new perspective on lipid research in age-related macular degeneration. Prog Retin Eye Res 67:56\u201386. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.04.006","journal-title":"Prog Retin Eye Res"},{"key":"7062_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1167\/iovs.65.6.38","volume":"65","author":"P Barreto","year":"2024","unstructured":"Barreto P, Farinha C, Coimbra R et al (2024) Unveiling statins and genetics in Age-Related macular degeneration: the Coimbra eye Study\u2014Report 9. Invest Ophthalmol Vis Sci 65:38. https:\/\/doi.org\/10.1167\/iovs.65.6.38","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7062_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006927.pub5","author":"P Gehlbach","year":"2016","unstructured":"Gehlbach P, Li T, Hatef E (2016) Statins for age-related macular degeneration. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD006927.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"7062_CR8","doi-asserted-by":"publisher","first-page":"e83759","DOI":"10.1371\/journal.pone.0083759","volume":"8","author":"RH Guymer","year":"2013","unstructured":"Guymer RH, Baird PN, Varsamidis M et al (2013) Proof of concept, randomized, placebo-controlled study of the effect of Simvastatin on the course of Age-Related macular degeneration. PLoS One 8:e83759. https:\/\/doi.org\/10.1371\/journal.pone.0083759","journal-title":"PLoS One"},{"key":"7062_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4068\/cmj.2023.59.3.143","volume":"59","author":"MA Amini","year":"2023","unstructured":"Amini MA, Karbasi A, Vahabirad M et al (2023) Mechanistic insight into age-related macular degeneration (AMD): anatomy, epidemiology, genetics, pathogenesis, prevention, implications, and treatment strategies to pace AMD management. Chonnam Med J 59:143\u2013159. https:\/\/doi.org\/10.4068\/cmj.2023.59.3.143","journal-title":"Chonnam Med J"},{"key":"7062_CR10","doi-asserted-by":"publisher","first-page":"18280","DOI":"10.1038\/srep18280","volume":"5","author":"L Ma","year":"2015","unstructured":"Ma L, Wang Y, Du J et al (2015) The association between statin use and risk of age-related macular degeneration. Sci Rep 5:18280. https:\/\/doi.org\/10.1038\/srep18280","journal-title":"Sci Rep"},{"key":"7062_CR11","first-page":"3524","volume":"63","author":"D Ganesh","year":"2022","unstructured":"Ganesh D, Chiang JN, Corradetti G et al (2022) Effect of Statins on the age of onset of age-Related macular degeneration. Invest Ophthalmol Vis Sci 63:3524","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7062_CR12","first-page":"5715","volume":"65","author":"W-Y Lin","year":"2024","unstructured":"Lin W-Y, Wang J-J, Lai C-H et al (2024) The relationship between Statin therapy and the development of Age-related macular degeneration in patients with dyslipidemia: a Long-term cohort study in Taiwan. Invest Ophthalmol Vis Sci 65:5715","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7062_CR13","doi-asserted-by":"publisher","first-page":"e0252878","DOI":"10.1371\/journal.pone.0252878","volume":"16","author":"CA Ludwig","year":"2021","unstructured":"Ludwig CA, Vail D, Rajeshuni NA et al (2021) Statins and the progression of age-related macular degeneration in the united States. PLoS One 16:e0252878. https:\/\/doi.org\/10.1371\/journal.pone.0252878","journal-title":"PLoS One"},{"key":"7062_CR14","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1136\/bjo-2022-321985","volume":"107","author":"MM Mauschitz","year":"2023","unstructured":"Mauschitz MM, Verzijden T, Schuster AK et al (2023) Association of lipid-lowering drugs and antidiabetic drugs with age-related macular degeneration: a meta-analysis in Europeans. Br J Ophthalmol 107:1880\u20131886. https:\/\/doi.org\/10.1136\/bjo-2022-321985","journal-title":"Br J Ophthalmol"},{"key":"7062_CR15","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/biomedicines11061508","volume":"11","author":"C-H Chen","year":"2023","unstructured":"Chen C-H, Lin H-C, Lin H-L et al (2023) Association between antihyperlipidemic agent use and age-related macular degeneration in patients with hyperlipidemia: a population-based retrospective cohort study. Biomedicines 11:1508. https:\/\/doi.org\/10.3390\/biomedicines11061508","journal-title":"Biomedicines"},{"key":"7062_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/157488608783333952","volume":"3","author":"M Etminan","year":"2008","unstructured":"Etminan M, Brophy JM, Maberley D (2008) Use of statins and angiotensin converting enzyme inhibitors (ACE-Is) and the risk of age-related macular degeneration: nested case-control study. Curr Drug Saf 3:24\u201326. https:\/\/doi.org\/10.2174\/157488608783333952","journal-title":"Curr Drug Saf"},{"key":"7062_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1167\/iovs.66.1.25","volume":"66","author":"B Kayembe-Mulumba","year":"2025","unstructured":"Kayembe-Mulumba B, Leffondr\u00e9 K, Joly P et al (2025) Unveiling statins and genetics in age-related macular degeneration progression: what is the appropriate modeling strategy? Invest Ophthalmol Vis Sci 66:25. https:\/\/doi.org\/10.1167\/iovs.66.1.25","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7062_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000072920","volume":"22","author":"The 3C Study Group","year":"2003","unstructured":"The 3\u00a0C Study Group (2003) Vascular factors and risk of dementia: design of the Three-City study and baseline characteristics of the study population. Neuroepidemiology 22:316\u2013325. https:\/\/doi.org\/10.1159\/000072920","journal-title":"Neuroepidemiology"},{"key":"7062_CR19","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s12603-010-0131-9","volume":"14","author":"C Delcourt","year":"2010","unstructured":"Delcourt C, Korobelnik J-F, Barberger-Gateau P et al (2010) Nutrition and Age-Related eye diseases: the ALIENOR (Antioxydants, lipides Essentiels, nutrition et maladies OculaiRes) study. J Nutr Health Aging 14:854\u2013861","journal-title":"J Nutr Health Aging"},{"key":"7062_CR20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/s0039-6257(05)80092-x","volume":"39","author":"AC Bird","year":"1995","unstructured":"Bird AC, Bressler NM, Bressler SB et al (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The international ARM epidemiological study group. Surv Ophthalmol 39:367\u2013374. https:\/\/doi.org\/10.1016\/s0039-6257(05)80092-x","journal-title":"Surv Ophthalmol"},{"key":"7062_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ophtha.2005.12.013","volume":"113","author":"R Klein","year":"2006","unstructured":"Klein R, Klein BEK, Knudtson MD et al (2006) Prevalence of age-related macular degeneration in 4 racial\/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 113:373\u2013380. https:\/\/doi.org\/10.1016\/j.ophtha.2005.12.013","journal-title":"Ophthalmology"},{"key":"7062_CR22","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","volume":"120","author":"FL Ferris","year":"2013","unstructured":"Ferris FL, Wilkinson CP, Bird A et al (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120:844\u2013851. https:\/\/doi.org\/10.1016\/j.ophtha.2012.10.036","journal-title":"Ophthalmology"},{"key":"7062_CR23","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1016\/j.numecd.2024.05.021","volume":"34","author":"L Alvarez-Jimenez","year":"2024","unstructured":"Alvarez-Jimenez L, Morales-Palomo F, Moreno-Caba\u00f1as A et al (2024) Time-course atherogenic blood lipid response to statin discontinuation in dyslipidemic adults. Nutr Metab Cardiovasc Dis 34:2334\u20132343. https:\/\/doi.org\/10.1016\/j.numecd.2024.05.021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"7062_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2188\/jea.JE20190192","volume":"30","author":"E Suzuki","year":"2020","unstructured":"Suzuki E, Shinozaki T, Yamamoto E (2020) Causal diagrams: pitfalls and tips. J Epidemiol 30:153\u2013162. https:\/\/doi.org\/10.2188\/jea.JE20190192","journal-title":"J Epidemiol"},{"key":"7062_CR25","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/09637486.2017.1287884","volume":"68","author":"F Sofi","year":"2017","unstructured":"Sofi F, Dinu M, Pagliai G et al (2017) Validation of a literature-based adherence score to Mediterranean diet: the MEDI-LITE score. Int J Food Sci Nutr 68:757\u2013762. https:\/\/doi.org\/10.1080\/09637486.2017.1287884","journal-title":"Int J Food Sci Nutr"},{"key":"7062_CR26","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.ophtha.2020.11.024","volume":"128","author":"JM Colijn","year":"2021","unstructured":"Colijn JM, Meester-Smoor M, Verzijden T et al (2021) Genetic Risk, Lifestyle, and Age-Related macular degeneration in europe: the EYE-RISK consortium. Ophthalmology 128:1039\u20131049. https:\/\/doi.org\/10.1016\/j.ophtha.2020.11.024","journal-title":"Ophthalmology"},{"key":"7062_CR27","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA (2015) Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 34:3661\u20133679. https:\/\/doi.org\/10.1002\/sim.6607","journal-title":"Stat Med"},{"key":"7062_CR28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/sim.9969","volume":"43","author":"EE Gabriel","year":"2024","unstructured":"Gabriel EE, Sachs MC, Martinussen T et al (2024) Inverse probability of treatment weighting with generalized linear outcome models for doubly robust estimation. Stat Med 43:534\u2013547. https:\/\/doi.org\/10.1002\/sim.9969","journal-title":"Stat Med"},{"key":"7062_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2007.02.047","volume":"144","author":"R Klein","year":"2007","unstructured":"Klein R, Knudtson MD, Klein BEK (2007) Statin use and the five-year incidence and progression of age-related macular degeneration. Am J Ophthalmol 144:1-6.e1. https:\/\/doi.org\/10.1016\/j.ajo.2007.02.047","journal-title":"Am J Ophthalmol"},{"key":"7062_CR30","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1016\/j.ophtha.2009.06.055","volume":"116","author":"MG Maguire","year":"2009","unstructured":"Maguire MG, Ying G, McCannel CA et al (2009) Statin use and the incidence of advanced age-related macular degeneration in the complications of age-related macular degeneration prevention trial. Ophthalmology 116:2381\u20132385. https:\/\/doi.org\/10.1016\/j.ophtha.2009.06.055","journal-title":"Ophthalmology"},{"key":"7062_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1136\/bmj.323.7309.375","volume":"323","author":"NF Hall","year":"2001","unstructured":"Hall NF, Gale CR, Syddall H et al (2001) Risk of macular degeneration in users of statins: cross sectional study. BMJ 323:375\u2013376","journal-title":"BMJ"},{"key":"7062_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.21037\/aes-21-20","volume":"6","author":"MA Mainster","year":"2021","unstructured":"Mainster MA, Al-Janabi A, Andrade ABM, Ledesma-Gil G (2021) Statins for age related macular degeneration: promising but unproven. Ann Eye Sci 6:34\u201334. https:\/\/doi.org\/10.21037\/aes-21-20","journal-title":"Ann Eye Sci"},{"key":"7062_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/14728222.2020.1737015","volume":"24","author":"S Mehrzadi","year":"2020","unstructured":"Mehrzadi S, Hemati K, Reiter RJ, Hosseinzadeh A (2020) Mitochondrial dysfunction in age-related macular degeneration: melatonin as a potential treatment. Expert Opin Ther Targets 24:359\u2013378. https:\/\/doi.org\/10.1080\/14728222.2020.1737015","journal-title":"Expert Opin Ther Targets"},{"key":"7062_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrcardio.2013.80","volume":"10","author":"\u017d Reiner","year":"2013","unstructured":"Reiner \u017d (2013) Statins in the primary prevention of cardiovascular disease. Nat Rev Cardiol 10:453\u2013464. https:\/\/doi.org\/10.1038\/nrcardio.2013.80","journal-title":"Nat Rev Cardiol"},{"key":"7062_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","volume":"393","author":"J Armitage","year":"2019","unstructured":"Armitage J, Baigent C, Barnes E et al (2019) Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet 393:407\u2013415. https:\/\/doi.org\/10.1016\/S0140-6736(18)31942-1","journal-title":"Lancet"},{"key":"7062_CR36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.preteyeres.2009.08.001","volume":"28","author":"CA Curcio","year":"2009","unstructured":"Curcio CA, Johnson M, Huang J-D, Rudolf M (2009) Aging, age-related macular degeneration, and the response-to-retention of Apolipoprotein B-containing lipoproteins. Prog Retin Eye Res 28:393. https:\/\/doi.org\/10.1016\/j.preteyeres.2009.08.001","journal-title":"Prog Retin Eye Res"},{"key":"7062_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1742-7843.2006.pto_293.x","volume":"98","author":"RJ Glynn","year":"2006","unstructured":"Glynn RJ, Schneeweiss S, St\u00fcrmer T (2006) Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol 98:253\u2013259. https:\/\/doi.org\/10.1111\/j.1742-7843.2006.pto_293.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"7062_CR38","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/biostatistics\/3.3.433","volume":"3","author":"P Joly","year":"2002","unstructured":"Joly P, Commenges D, Helmer C, Letenneur L (2002) A penalized likelihood approach for an illness\u2013death model with interval-censored data: application to age\u2010specific incidence of dementia. Biostatistics 3:433\u2013443. https:\/\/doi.org\/10.1093\/biostatistics\/3.3.433","journal-title":"Biostatistics"},{"key":"7062_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v079.i07","volume":"79","author":"C Touraine","year":"2017","unstructured":"Touraine C, Gerds TA, Joly P (2017) Smoothhazard: an R package for fitting regression models to interval-censored observations of illness-death models. J Stat Softw 79:1\u201322. https:\/\/doi.org\/10.18637\/jss.v079.i07","journal-title":"J Stat Softw"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07062-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-07062-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07062-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:13:11Z","timestamp":1772791991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-07062-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["7062"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-07062-7","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in the study ALIENOR were in accordance with the ethical standards of the Bordeaux Ethics Committee (Comit\u00e9 de Protection des Personnes Sud-Ouest et Outre-Mer III, Code 2006\/10) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"An informed, written and signed consent was obtained from all individual participants included in the ALIENOR study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Blondy Kayembe-Mulumba, Karen Leffondr\u00e9, Petra P. Larsen and \u00c9milie Hucteau certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript. Jean-Fran\u00e7ois Korobelnik has received consulting fees from Abbvie, Apellis, Bayer, Eyepoint Pharma, Ocuphire, Ocular Therapeutix, Roche, Th\u00e9a Pharma, and Carl Zeiss Meditec. C\u00e9cile Delcourt has received consulting fees from Allergan, Apellis, Th\u00e9a Pharma, and Novartis. Marie-No\u00eblle Delyfer has received consulting fees from Abbvie, Bayer, Horus Pharma, Novartis, Roche and Thea.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}